MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.390
+0.080 (6.11%)
Mar 31, 2026, 2:45 PM EDT - Market open
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $84.33 million as of March 31, 2026. Its market cap has increased by 94.54% in one year.
Market Cap
84.33M
Enterprise Value
70.82M
1-Year Change
94.54%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $84.33M, an increase of 65.03%. That is a compound annual growth rate of 14.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 79.48M | 35.75% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verrica Pharmaceuticals | 81.77M |
| Champions Oncology | 81.10M |
| PolyPid | 80.34M |
| Spruce Biosciences | 80.31M |
| Pyxis Oncology | 79.80M |
| Aardvark Therapeutics | 79.41M |
| Vivani Medical | 79.40M |
| OKYO Pharma | 79.24M |